{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:25:18Z","timestamp":1790857518405,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Research to Prevent Blindness"],"award-info":[{"award-number":["Research to Prevent Blindness"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frederic C. Hamilton Macular Degeneration Foundation","award":["Frederic C. Hamilton Macular Degeneration Foundation"],"award-info":[{"award-number":["Frederic C. Hamilton Macular Degeneration Foundation"]}]},{"name":"Helene and Marshall Abrahams AMD Research Fund","award":["Helene and Marshall Abrahams AMD Research Fund"],"award-info":[{"award-number":["Helene and Marshall Abrahams AMD Research Fund"]}]},{"name":"NIH\/NCATS Colorado","award":["UM1 TR004399"],"award-info":[{"award-number":["UM1 TR004399"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00417-025-07084-1","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T08:20:59Z","timestamp":1766218859000},"page":"927-934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Visual functioning and geographic atrophy imaging characteristics in age-related macular degeneration"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-0698","authenticated-orcid":false,"given":"Jennifer","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talisa E.","family":"de Carlo Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soufiane","family":"Azargui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Lisker-Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Gnanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mandava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"7084_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","volume":"140","author":"DB Rein","year":"2022","unstructured":"Rein DB, Wittenborn JS, Burke-Conte Z et al (2022) Prevalence of age-related macular degeneration in the US in 2019. JAMA Ophthalmol 140:1202. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4401","journal-title":"JAMA Ophthalmol"},{"key":"7084_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106\u2013e116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"7084_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","volume":"160","author":"AR Rudnicka","year":"2015","unstructured":"Rudnicka AR, Kapetanakis VV, Jarrar Z et al (2015) Incidence of late-stage age-related macular degeneration in American Whites: systematic review and meta-analysis. Am J Ophthalmol 160:85-93.e3. https:\/\/doi.org\/10.1016\/j.ajo.2015.04.003","journal-title":"Am J Ophthalmol"},{"key":"7084_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/archopht.123.3.321","volume":"123","author":"JM Seddon","year":"2005","unstructured":"Seddon JM (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321. https:\/\/doi.org\/10.1001\/archopht.123.3.321","journal-title":"Arch Ophthalmol"},{"key":"7084_CR5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147\u20131159. https:\/\/doi.org\/10.1016\/S0140-6736(18)31550-2","journal-title":"Lancet"},{"key":"7084_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00132578-200201000-00028","volume":"3","author":"AL Coleman","year":"2002","unstructured":"Coleman AL (2002) Development of the 25-item National Institute visual function questionnaire. Evid-Based Eye Care 3:58\u201359. https:\/\/doi.org\/10.1097\/00132578-200201000-00028","journal-title":"Evid-Based Eye Care"},{"key":"7084_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/aos.14731","volume":"99","author":"JL Patnaik","year":"2021","unstructured":"Patnaik JL, Lynch AM, Pecen PE et al (2021) The impact of advanced age-related macular degeneration on the National Eye Institute\u2019s visual function questionnaire\u201025. Acta Ophthalmol (Copenh) 99:750\u2013755. https:\/\/doi.org\/10.1111\/aos.14731","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"7084_CR8","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2147\/OPTH.S246245","volume":"14","author":"N Burguera-Gim\u00e9nez","year":"2020","unstructured":"Burguera-Gim\u00e9nez N, Garc\u00eda-L\u00e1zaro S, Espa\u00f1a-Gregori E et al (2020) Multimodal evaluation of visual function in geographic atrophy versus normal eyes. Clin Ophthalmol Volume 14:1533\u20131545. https:\/\/doi.org\/10.2147\/OPTH.S246245","journal-title":"Clin Ophthalmol Volume"},{"key":"7084_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2016.1181192","volume":"32","author":"I Chatziralli","year":"2017","unstructured":"Chatziralli I, Mitropoulos P, Parikakis E et al (2017) Risk factors for poor quality of life among patients with age-related macular degeneration. Semin Ophthalmol 32:772\u2013780. https:\/\/doi.org\/10.1080\/08820538.2016.1181192","journal-title":"Semin Ophthalmol"},{"key":"7084_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaophthalmol.2016.0794","volume":"134","author":"F Choudhury","year":"2016","unstructured":"Choudhury F, Varma R, Klein R et al (2016) Age-related macular degeneration and quality of life in latinos: the Los Angeles Latino eye study. JAMA Ophthalmol 134:683. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.0794","journal-title":"JAMA Ophthalmol"},{"key":"7084_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/IAE.0000000000002023","volume":"39","author":"AM Lynch","year":"2019","unstructured":"Lynch AM, Patnaik JL, Cathcart JN et al (2019) Colorado age-related macular degeneration registry: design and clinical risk factors of the cohort. Retina 39:656\u2013663. https:\/\/doi.org\/10.1097\/IAE.0000000000002023","journal-title":"Retina"},{"key":"7084_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844\u2013851. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.036","journal-title":"Ophthalmology"},{"key":"7084_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG et al (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT. Ophthalmology 125:537\u2013548. https:\/\/doi.org\/10.1016\/j.ophtha.2017.09.028","journal-title":"Ophthalmology"},{"issue":"7","key":"7084_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM (2001) The National Eye Institute 25-item visual function questionnaire (VFQ-25). Arch Ophthalmol 119(7):1050\u20131058. https:\/\/doi.org\/10.1001\/archopht.119.7.1050","journal-title":"Arch Ophthalmol"},{"key":"7084_CR15","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.5.10","volume":"11","author":"JE Goldstein","year":"2022","unstructured":"Goldstein JE, Bradley C, Gross AL et al (2022) The NEI VFQ-25C: calibrating items in the National Eye Institute visual function questionnaire-25 to enable comparison of outcome measures. Transl Vis Sci Technol 11:10. https:\/\/doi.org\/10.1167\/tvst.11.5.10","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"7084_CR16","doi-asserted-by":"publisher","first-page":"e0206106","DOI":"10.1371\/journal.pone.0206106","volume":"13","author":"C Bradley","year":"2018","unstructured":"Bradley C, Massof RW (2018) Method of successive dichotomizations: an improved method for estimating measures of latent variables from rating scale data. PLoS One 13(10):e0206106. https:\/\/doi.org\/10.1371\/journal.pone.0206106","journal-title":"PLoS One"},{"key":"7084_CR17","unstructured":"Clemons TE, Chew EY, Bressler SB, McBee W (2006) National Eye Institute Visual Function Questionnaire in the Age- Related Eye Disease Study (AREDS)"},{"key":"7084_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajo.2010.05.030","volume":"150","author":"AL Coleman","year":"2010","unstructured":"Coleman AL, Yu F, Ensrud KE et al (2010) Impact of Age-Related macular degeneration on vision-specific quality of life: follow-up from the 10-year and 15-year visits of the study of osteoporotic fractures. Am J Ophthalmol 150:683\u2013691. https:\/\/doi.org\/10.1016\/j.ajo.2010.05.030","journal-title":"Am J Ophthalmol"},{"key":"7084_CR19","doi-asserted-by":"publisher","unstructured":"(2005) Responsiveness of the National eye Institute visual function questionnaire to progression to advanced Age-Related macular Degeneration, vision Loss, and lens opacity: AREDS report 14. Arch Ophthalmol 123:1207. https:\/\/doi.org\/10.1001\/archopht.123.9.1207","DOI":"10.1001\/archopht.123.9.1207"},{"key":"7084_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12886-023-02901-9","volume":"23","author":"D-ML Holm","year":"2023","unstructured":"Holm D-ML, Nielsen MK, H\u00f8jsted BB, S\u00f8rensen TL (2023) Vision-related quality of life is selectively affected by comorbidities in patients with geographic atrophy. BMC Ophthalmol 23:153. https:\/\/doi.org\/10.1186\/s12886-023-02901-9","journal-title":"BMC Ophthalmol"},{"key":"7084_CR21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.5.63","volume":"61","author":"SH K\u00fcnzel","year":"2020","unstructured":"K\u00fcnzel SH, M\u00f6ller PT, Lindner M et al (2020) Determinants of quality of life in geographic atrophy secondary to Age-Related macular degeneration. Invest Ophthalmol Vis Sci 61:63. https:\/\/doi.org\/10.1167\/iovs.61.5.63","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7084_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00417-022-05849-6","volume":"261","author":"A Ahluwalia","year":"2023","unstructured":"Ahluwalia A, Shen LL, Bao Y et al (2023) The influence of the topographic location of geographic atrophy on vision-related quality of life in nonexudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 261:699\u2013708. https:\/\/doi.org\/10.1007\/s00417-022-05849-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7084_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/archopht.120.5.579","volume":"120","author":"C Bellmann","year":"2002","unstructured":"Bellmann C, Jorzik, Jork, Spital G et al (2002) Symmetry of bilateral lesions in geographic atrophy in patients with Age-Related macular degeneration. Arch Ophthalmol 120:579. https:\/\/doi.org\/10.1001\/archopht.120.5.579","journal-title":"Arch Ophthalmol"},{"key":"7084_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG et al (2023) Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet 402:1434\u20131448. https:\/\/doi.org\/10.1016\/S0140-6736(23)01520-9","journal-title":"Lancet"},{"key":"7084_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani AM, Patel SS, Staurenghi G et al (2023) Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet 402:1449\u20131458. https:\/\/doi.org\/10.1016\/S0140-6736(23)01583-0","journal-title":"Lancet"},{"key":"7084_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12886-016-0274-5","volume":"16","author":"C Owsley","year":"2016","unstructured":"Owsley C, McGwin G (2016) Vision-targeted health related quality of life in older adults: patient-reported visibility problems in low luminance activities are more likely to decline than daytime activities. BMC Ophthalmol 16:92. https:\/\/doi.org\/10.1186\/s12886-016-0274-5","journal-title":"BMC Ophthalmol"},{"key":"7084_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.03.025","volume":"16","author":"J Petrillo","year":"2013","unstructured":"Petrillo J, Ferreira A, Cano S et al (2013) Psychometric performance of the Nei Vfq-25: Rasch analysis of the Nei Vfq-25 as a measure of patient-reported visual function across four retinal diseases. Value Health 16:A4. https:\/\/doi.org\/10.1016\/j.jval.2013.03.025","journal-title":"Value Health"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07084-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:37:08Z","timestamp":1773909428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07084-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7084"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07084-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No other financial disclosures exist for the remaining authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Colorado and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"de Carlo Forest: Genentech (advisory board), Patnaik: Orbis (consulting), GoCheckKids (consulting), Palestine: Tarsier Pharma, Manoharan: Iveric Bio (financial research support), Genentech (consulting), Mandava: SomaLogic (consulting, research), ONL Therapeutics (consulting), Alcon (patent), 2 C Tech (patent, equity, co-founder), Aurea Medical (equity, co-founder).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}